10.03.2026 /
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
Equality in research drives innovation
2026 “Jugend forscht” Berlin-Buch regional winners
